Beijing Innocare Pharma Tech Co., Ltd.

This study tested an experimental drug called ICP-022 in 106 adults with mantle cell lymphoma that had come back or stopped responding to prior treatments. The goal was to see if the drug could shrink tumors and to check its safety. The approach focuses on controlling the disease…

This study tested whether adding orelabrutinib to standard chemotherapy (R-CHOP) helps people with untreated mantle cell lymphoma live longer without the disease getting worse. It included adults aged 60 to 80 who had not received prior treatment. The main goal was to see if the …